This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2021 Sep;48(9):1358-1360.

doi: 10.3899/jrheum.210138. Epub 2021 May 15.

Among the Company That Gout Keeps, Is Cancer on the List?

Allan C Gelber¹

Affiliations

PMID: 33993111
DOI: 10.3899/jrheum.210138

Editorial

Among the Company That Gout Keeps, Is Cancer on the List?

Allan C Gelber. J Rheumatol. 2021 Sep.

. 2021 Sep;48(9):1358-1360.

doi: 10.3899/jrheum.210138. Epub 2021 May 15.

Author

Allan C Gelber¹

Affiliation

¹ A.C. Gelber, MD, MPH, PhD, Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. agelber@jhmi.edu.

PMID: 33993111
DOI: 10.3899/jrheum.210138

No abstract available

PubMed Disclaimer

Comment on

Risk of Cancer in Middle-aged Patients With Gout: A Nationwide Population-based Study in Korea.
Lee JS, Myung J, Lee HA, Hong S, Lee CK, Yoo B, Oh JS, Kim YG. Lee JS, et al. J Rheumatol. 2021 Sep;48(9):1465-1471. doi: 10.3899/jrheum.200497. Epub 2020 Nov 15. J Rheumatol. 2021. PMID: 33191287

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information